HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prevailing ethical dilemmas in terminal care for patients with cancer in Taiwan.

AbstractPURPOSE:
The study aimed to investigate prevailing ethical dilemmas in terminal care for patients with cancer nationwide and identify related factors after the enactment of the Natural Death Act in Taiwan.
METHODS:
This multicenter study surveyed 800 physicians and nursing staff of oncology wards and hospices through a set questionnaire. A total of 505 respondents (63.1%) who had taken care of patients with terminal cancer were analyzed.
RESULTS:
The most frequently encountered ethical dilemmas were truth-telling (mean +/- SD = 1.30 +/- 0.63; range [never, occasional, often], 0 to 2) and place of care (1.19 +/- 0.69), both of which were related to communication issues. Dilemmas related to clinical management were artificial nutrition and hydration (1.04 +/- 0.66) and use of antimicrobial agents (0.94 +/- 0.70). Logistic regression analyses revealed that positive attitudes about the Natural Death Act was negatively related to the extent of ethical dilemmas (odds ratio, 0.426; 95% CI, 0.256 to 0.710].
CONCLUSION:
The enactment of the Natural Death Act in Taiwan would contribute to improving the quality of end-of-life care, which suggests that this kind of law should be adopted in other countries. Educating cancer care professionals in building positive beliefs toward the act is strongly encouraged.
AuthorsTai-Yuan Chiu, Wen-Yu Hu, Hsien-Liang Huang, Chien-An Yao, Ching-Yu Chen
JournalJournal of clinical oncology : official journal of the American Society of Clinical Oncology (J Clin Oncol) Vol. 27 Issue 24 Pg. 3964-8 (Aug 20 2009) ISSN: 1527-7755 [Electronic] United States
PMID19470919 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Topics
  • Adult
  • Attitude of Health Personnel
  • Cross-Sectional Studies
  • Female
  • Humans
  • Male
  • Neoplasms (therapy)
  • Palliative Care
  • Taiwan
  • Terminal Care (ethics)
  • Truth Disclosure (ethics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: